Stay updated on Azacitidine and Pembrolizumab in MDS Clinical Trial
Sign up to get notified when there's something new on the Azacitidine and Pembrolizumab in MDS Clinical Trial page.

Latest updates to the Azacitidine and Pembrolizumab in MDS Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe page revision label changed from v3.6.5 to v3.6.6, indicating a small maintenance release. This signals a new version of the page without altering substantive content.SummaryDifference0.1%

- Check28 days agoNo Change Detected
- Check42 days agoChange DetectedThe page's revision label has advanced from v3.6.4 to v3.6.5, signaling an update to the site's revision version. This appears to be a metadata/version bump and does not modify the study content or user-facing features.SummaryDifference0.1%

- Check57 days agoChange DetectedA new page revision tag Revision: v3.6.4 appears, replacing Revision: v3.6.3, indicating a small update to the page's version.SummaryDifference0.1%

- Check78 days agoChange DetectedA new page revision tag v3.6.3 was added, indicating a small update to the page version. This reflects a minor backend/content update rather than a substantive change to the study details.SummaryDifference0.1%

- Check85 days agoChange DetectedThe revision label on the page was updated from v3.6.0 to v3.6.2. This indicates a newer version without altering substantive content.SummaryDifference0.1%

- Check100 days agoChange DetectedUI labels and navigation elements have been updated on the study details page, including new sections such as 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study', and the 'Intervention/Treatment' heading with an updated revision footnote. Additionally, new metadata labels 'Last verified' and 'Last known status was' were added.SummaryDifference2%

Stay in the know with updates to Azacitidine and Pembrolizumab in MDS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Azacitidine and Pembrolizumab in MDS Clinical Trial page.